A study of 71 patients with castration-resistant metastatic prostate cancer who had gallium (Ga)-PSMA-11 PET/CT scan and then were treated with 177Lu-PSMA-617 radioligand therapy over a three-year period. Here, FOLH1 is linked to metastatic prostate carcinoma.